Serina Therapeutics, Inc. Q3 FY2021 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2021 Q3 Call date: 2021-11-12 Concluded

Quarter scorecard

Revenue

$24,000

-65.2% YoY

Gross margin

91.7%

+16.3 pp YoY

Net income

Grant Revenues $22,000

-45%

Other Revenues $2,000

-93.1%